BioPharma & Healthcare Related News

Flagship Pioneering Announces Launch of Sigilon Therapeutics to Harness the Full Power of Cell Therapeutics

Flagship Pioneering announced the launch of its newest biotech firm, Sigilon Therapeutics on Wednesday, June 21st, with  a $23.5 million round of financing and is the latest company in a line of Cambridge/Boston biotechs to come out of VentureLabs, Flagship’s in-house [...]

By | July 5th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Synlogic Receives Fast Track Designation in U.S. for Lead Candidate, SYNB1020

June 26, 2017 07:15 AM Eastern Daylight Time  - CAMBRIDGE, Mass–(BUSINESS WIRE)–Synlogic™ has been granted Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its lead product candidate, SYNB1020, as an oral, investigational medicine for the treatment of [...]

By | June 26th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Intellia Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China

CAMBRIDGE, Mass., June 19, 2017 (GLOBE NEWSWIRE) — Intellia Therapeutics (NASDAQ: NTLA), a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR technology, today announced that China’s State Intellectual Property Office (“SIPO”) has indicated that [...]

By | June 20th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

CRISPR Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China

BASEL, Switzerland, June 19, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announced that China’s State Intellectual Property Office (“SIPO”) has granted a patent broadly covering CRISPR’s in-licensed gene [...]

By | June 20th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Eligo Bioscience Awarded as Technology Pioneer by World Economic Forum

Paris, June 14, 2017 – Eligo Bioscience, the Paris-based start-up that seeks to enable precise engineering of the microbiome, was chosen among hundreds of candidates as one of the World Economic Forum’s “technology pioneers,” a selection of the world’s most [...]

By | June 14th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Intellia Therapeutics and San Raffaele University and Research Hospital to Combine CRISPR/Cas9 Genome Editing with Enhanced Cell Therapies to Fight Cancer

CAMBRIDGE, Mass., and MILAN, Italy, June 6, 2017 (GLOBEWIRE) – Intellia Therapeutics (NASDAQ:NTLA), a leading genome editing company, and San Raffaele University and Research Hospital, a leading scientific institution, have entered into a three-year research collaboration, option and license agreement [...]

By | June 7th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|